Unveiling the C9orf72 gene mystery: a key to dementia and ALS?

Have you ever heard of frontotemporal dementia (FTD) or amyotrophic lateral sclerosis (ALS)? These are brain and nerve diseases that are becoming more common. Well, a Portuguese study made an important discovery: 11% of the patients studied have a 'typo' in a gene called C9orf72. This typo is like a repeating sequence of letters in the DNA instruction manual. Scientists found that most of these expansions are very long and are the main cause of the diseases. But the most interesting part? They also found people with 'intermediate' expansions—neither normal nor fully disease-causing. And these individuals with shorter expansions already show clinical signs similar to those with long expansions! This suggests that these intermediate variants can also be a risk factor. The conclusion? Genetic testing for C9orf72 is crucial for better understanding these diseases, especially in Europe.

In the study, researchers analyzed 610 patients and 63 healthy relatives using a two-step PCR technique to count the repeats in the C9orf72 gene. They identified three patients with shorter expansions (from 38 to 78 repeats), which is unusual compared to the majority who have over 145 repeats. The seven individuals with intermediate alleles underwent comprehensive clinical, fluid-biomarker, and neuropsychological testing. The results show that it's not just the presence of the expansion that matters, but also its length. Intermediate expansions seem sufficient to trigger a pathological pathway, though they are less penetrant than very long expansions. This explains why some individuals with intermediate alleles develop symptoms while others do not, highlighting the complexity of these diseases.